Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Capital Expenditures (2020 - 2025)

Agilon Health (AGL) has disclosed Capital Expenditures for 6 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 9.12% year-over-year to $3.0 million, compared with a TTM value of $13.2 million through Dec 2025, changed 0.07%, and an annual FY2025 reading of $13.2 million, changed 0.07% over the prior year.
  • Capital Expenditures was $3.0 million for Q4 2025 at Agilon Health, down from $3.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $4.5 million in Q2 2022 and bottomed at $178000.0 in Q1 2021.
  • Average Capital Expenditures over 5 years is $3.2 million, with a median of $3.4 million recorded in 2021.
  • The sharpest move saw Capital Expenditures plummeted 48.41% in 2021, then skyrocketed 2174.72% in 2022.
  • Year by year, Capital Expenditures stood at $3.4 million in 2021, then rose by 2.62% to $3.5 million in 2022, then increased by 12.7% to $3.9 million in 2023, then decreased by 16.94% to $3.3 million in 2024, then fell by 9.12% to $3.0 million in 2025.
  • Business Quant data shows Capital Expenditures for AGL at $3.0 million in Q4 2025, $3.2 million in Q3 2025, and $3.2 million in Q2 2025.